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Patients who are symptomatic with a >70% carotid
stenosis who undergo carotid endarterectomy (CEA)
have an improved prognosis as compared with those
patients who undergo medical treatment, as docu-
mented by the North American Symptomatic Carotid
Endarterectomy Trial.1 Operative repair is not without
potential complications, one of which is postoperative
restenosis. The overall restenosis rate can be as high as
31%.2 Recently, recurrent stenosis of >50% was found
in nearly 11% of 409 arteries at a 42-month follow-up.
Stenoses of >80%, including occlusion, developed in as
much as 2.1% of these arteries. The cumulative 5-year
ipsilateral stroke rate in patients with recurrent steno-
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Purpose: This preliminary study investigated the ability to elevate the serum homocys-
teine (H[e]) levels and investigated the increases in postoperative neointimal hyperpla-
sia (IH) in an environment with hyperhomocysteinemia and the resultant restenosis in a
rat carotid endarterectomy (CEA) model.
Method: The 9 rats for the control group were fed rat chow, and the 8 rats for the H(e)
group were fed H(e)-supplemented rat chow for 2 weeks before and after CEA. The ani-
mals underwent anesthesia, and a left common CEA was performed. After 14 days, the
serum H(e) levels were measured and the left carotid artery was harvested and elastin
stained. Morphometric measurements were used to calculate the area of stenosis of the
lumen. The mean and the standard deviation of the mean were determined. The 2
groups were compared with the Mann-Whitney test and a linear regression model. Three
additional rats per group were studied, with carotid artery sectioning with double
immunohistochemical staining for 5-bromodeoxyuridine (BrdU) and a –smooth muscle
(a -SM) actin.
Results: The serum H(e) level in the H(e) group was 36.32 m mol/L ± 15.28, and in the
control group the level was 5.53 m mol/L ± 2.06 (P = .0007). IH presented as percent
lumen stenosis was 21.89% ± 4.82% in the H(e) group and 4.82% ± 1.64% in the con-
trol group (P = .0007). The linear regression model of the serum H(e) levels and the
percent stenosis showed a linear relationship (r2 = .72). The a -SM actin staining revealed
that nearly all of the cells in the IH area were of smooth muscle or myofibroblast origin
and that 10.1% ± 2.6% of the cells were stained for BrdU in the control group versus
23% ± 7.1% in the H(e) group. Also, 9.3% ± 2.6% of the cells in the IH area were stained
for BrdU and for a -SM actin versus 19.1% ± 5.6% stained for both BrdU and a -SM
actin in the H(e) group.
Conclusion: This is the first study to examine IH after CEA and hyperhomocysteinemia
in rats. The study shows that the elevation of serum H(e) levels can be obtained by feed-
ing rats modified diets with added H(e). The consistent elevation of serum H(e) levels
was associated with more than 4 times the amount of IH after a CEA in a rat model. 
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sis was 5.6%.3 The causes of restenosis are neointimal
hyperplasia (IH), recurrent atherosclerosis, arterial
wall remodeling, and technical problems. In addition
to CEA, IH is a complicating problem in other areas
of artery manipulation, such as angioplasty, stenting,
and venous arterial anastomosis for bypass graft proce-
dures.4 These lesions occur primarily as a result of
smooth muscle cell proliferation and migration and
result in restenosis.5 Many theories exist regarding the
pathophysiology of IH, but no overall scheme has
emerged. This work studies the relationship between
IH and homocysteine (H[e]). The results could lead
to a clearer understanding of IH pathophysiology and
potentially identify a treatable etiologic factor.
H(e), a non–protein–forming sulfur amino acid,
is metabolized by remethylation to methionine or by
transsulfuration to cysteine.6 H(e) elevation may
result from inherited disorders of enzyme activity or
from enzyme cofactor deficiencies of cobalamin,
folate, or pyridoxine, with subsequent interruption of
H(e) metabolic pathways.7 Clinically, hyperhomocys-
teinemia is an independent risk factor for accelerated
occlusive vascular disease as concluded in a meta-
analysis of 27 studies.8 The Framingham Heart Study
showed that the incidence rate of carotid disease was
twice as high for patients with elevated plasma H(e)
concentrations.9 Elevated serum H(e) concentrations
are found in patients with asymptomatic carotid
artery disease10 and in 32% of patients with progres-
sion of carotid artery disease to the next category of
stenosis when followed up with noninvasive test-
ing.11 The association between plasma H(e) concen-
trations and >25% carotid artery stenosis is indepen-
dent of known risk factors, and the risk of stenosis
was elevated in subjects with H(e) concentrations of
>11.4 m mol/L.9 These studies show an association of
elevated H(e) with the progression and sequelae of
vascular disease. To our knowledge, no study investi-
gates the relationship between the restenosis of CEA
as a result of IH and the serum H(e) levels. We chose
to investigate this relationship in a rat model.
This study was designed to investigate the ability
to consistently elevate serum H(e) levels with dietary
modification and then to use the diet in a rat
endarterectomy model to determine the influence of
hyperhomocysteinemia on IH. Our hypothesis was
that hyperhomocysteinemia would increase the
amount of postoperative IH and the amount of
resultant lumen stenosis in a rat CEA model.
MATERIALS AND METHODS
Randomly numbered Sprague-Dawley rats (weight
range, 325 to 350 g) were used for the study. A con-
trol group of 9 rats was given water ad libitum and fed
a diet that was L-amino acid defined, choline and iron
supplemented, and pelleted (Diet #518754, Dyets,
Inc, Bethlehem, Pa). The H(e) group of 8 rats was
given water ad libitum and was fed a diet that was L-
amino acid defined, choline deficient, iron supple-
mented, and pelleted, without folic acid, methionine,
or choline, and with 4.5 g/kg of DL-H(e) (Diet
#518590, Dyets, Inc) for 2 weeks before operation.
The control group and the H(e) group diets were
matched for calories, protein content, vitamin mix-
tures, and minerals. However, the control group diet
had choline (14.48 g/kg), methionine (1.7 g/kg),
and folate (2 mg/kg), and the H(e) group diet was
deficient in these compounds. Also, the H(e) group
diet had an added 4.5 g/kg of DL-H(e). A full list-
ing of dietary components can be found in Table I.
The postoperative diets were the same as the preop-
erative diets.
Rat carotid endarterectomy. The animals
underwent sedation with isoflurane and anesthesia
with an intraperitoneal injection of ketamine
hydrochloride (80 mg/kg) and xylazine hydrochlo-
ride (10 mg/kg). After adequate anesthesia was con-
firmed with the lack of response to hind paw stimu-
lation, a subcutaneous injection of normal saline
solution (10 mL/kg) was administered in the upper
middle back, which served as a fluid bolus to com-
pensate for any intraoperative blood loss. A midline
cervical incision was made with a sterile technique
and a dissecting microscope (SZ40, Olympus,
Olympus America Inc, Melville, NY). The superficial
muscles were divided, and the dissection was carried
down to the level of the left carotid artery. The cer-
vical nerves in the region of the artery were dissect-
ed free to preserve pharyngeal function to prevent
postoperative respiratory compromise.
After adequate carotid artery exposure was
acheived, proximal and distal control at the bifurca-
tion (1.0 to 1.5 cm apart) was obtained with occlu-
sion tourniquets fashioned from 4-0 silk suture and
polyethylene 50 tubing. An arteriotomy was made
with a corneal blade and was extended to 6 mm in
length with micro-scissors. A 27-gauge needle was
used to transversely score the endothelial cell layer
and the media across the vessel in 2 parallel lines that
were approximately 4 mm apart. The endothelial cell
layer and the inner portion of the media then were
removed with micro-forceps. The arteriotomy was
closed with a running 10-0 monofilament nylon
suture (MS/9, Ethilon, Ethicon, Inc, Somerville,
NJ) with a tapered 3/8 circle needle (BV75-3,
Ethicon, Inc). The distal tourniquet was removed
JOURNAL OF VASCULAR SURGERY
910 Southern et al November 1998
first to assess suture line hemostasis and was followed
by the removal of the proximal occlusion tourniquet.
A sterile cotton-tipped applicator was applied gently
to any suture line bleeding until hemostasis was
achieved. After endarterectomy, the carotid artery
was assessed with a Doppler scan to confirm patency.
The superficial muscle layer was closed with a run-
ning 4-0 absorbable suture, and the skin was closed
with an interrupted suture. The rats were observed
after surgery, and, when they recovered from the
anesthesia, they were allowed to resume the same
diet that they had before surgery. The operating
investigator was blinded to the type of diet that each
rat was receiving.
Tissue harvesting. Two weeks after surgery,
the rats underwent anesthesia as before and the left
carotid artery was exposed. The abdomen was
opened at the midline, and the distal aorta and the
inferior vena cava were exposed. Blood (3 mL) was
withdrawn from the inferior vena cava for H(e)
determination. The inferior vena cava was transect-
ed, and the aortic root was cannulated with an 18-
gauge catheter. Normal saline solution was infused
at 100 mm Hg until the vena cava effluent ran clear,
and then a solution of 4% formaldehyde and 1% glu-
taraldehyde was infused at a constant pressure of
100 mm Hg in an equal volume to the saline infu-
sion to complete the perfusion-fixation process.
One-centimeter sections of the left carotid artery
were dissected free and placed in 10% formalin.
Morphometric analysis. The arteries were paraf-
fin blocked, sectioned, and elastin stained with
Verhoeff’s stain and van Geison’s stain. Two sections
per artery were taken from the middle one third of
the segments after endarterectomy as identified by the
proximal and distal limits of the continuous 10-0
nylon suture arteriotomy closure to standardize the
region of sectioning. The elastin-stained slides were
photographed, and the outline of the actual lumen
(the inner limit of IH) and of the outer limit of IH
were traced onto transparencies. The characteristic
pattern of IH was used to identify the demarcation
between the outer limits of IH and the media/adven-
titial layers. These outlines were digitized with a com-
puter scanner (Hewlett Packard Scanjet 6100C, Palo
Alto, Calif), and the morphometric area measure-
ments were performed with the National Institutes of
Health Software Image program, version 1.44
(Bethesda, Md). Because the arterial cross-sectional
shape is noncircular as a result of processing distor-
tion, the normalized area of the outer limit of IH was
calculated on the basis of the circumference of this
outer limit as described by Law et al.12 The actual
lumen area was measured. The difference between the
2 areas (outer limit of IH minus the actual lumen) was
determined as the area of IH. Because arterial cross
sections from different animals are not of constant
diameter, the amount of IH was calculated as the ratio
of the absolute area of IH to the outer limit of IH.14
This ratio, presented as the percent lumen stenosis
and as a main end point, represents the proportion of
the lumen area occupied by IH and allows the com-
parison of the arterial cross sections of varying sizes.12
The 2 sections from each vessel were traced, and the
circumference and area measurements were per-
formed by 2 blinded observers. Minimal variability
was seen between observer measurements.
H(e) measurement. H(e) is oxidized in body
fluids to the disulfides homocystine and cysteine-
H(e). These disulfides are reduced, and protein-
bound H(e) is released with tri-n-butylphosphine in
dimethylformamide, which allows the measurement
of the total plasma H(e) levels. After the thiols are
labeled with a thiol-specific fluorogenic reagent,
they are separated by a reverse-phase high-perfor-
mance liquid chromatographic method with fluores-
cence detection. A 4-point standard curve is carried
through the derivation procedure along with an
internal standard, cysteamine, for quantitation.13
Immunohistochemistry. To aid in the determi-
nation of the cell line of the origin involved with the
IH formation and to investigate whether the state of
replication is increased in the H(e) group as com-
pared with the control group, 3 additional rats per
group were studied with double immunohistochem-
ical staining for 5-bromodeoxyuridine (BrdU) and
a –smooth muscle (a -SM) actin.14 The rats were fed
their respective diets for 2 weeks before CEA. At 24
and 48 hours before the rats were killed, 2 weeks
after CEA, these animals were given 50 mg/kg
intraperitoneal of BrdU (Sigma, St Louis, Mo). The
carotid arteries were harvested and sectioned as pre-
viously described for the initial study groups.
The Vectastain Elite ABC Kit (Vector Laboratories,
Inc, Burlingame, Calif) was used for the immunohis-
tochemical staining. The sections underwent deparaf-
finization and were quenched with hydrogen peroxide
in methanol, placed in 2 N HCl for 1 hour, then
placed in 0.2% pepsin in 0.01 N HCl for 30 minutes,
and finally blocked with 10% goat serum (Vector
Laboratories, Inc). The sections were incubated first
with BrdU primary antibody and with monoclonal
mouse antibody (1:100, Sigma) for 2 hours, and then
with biotinylated secondary goat antimouse antibody
(1:400, Vector Laboratories, Inc) for 30 minutes
before incubation in the ABC reagent. The sections
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were developed with the peroxidase substrate solution,
diaminobenzidine, for 6 minutes. The sections then
were washed 3 times in phosphate buffered saline solu-
tion and blocked with 10% goat serum for 20 minutes.
The sections were incubated for 2 hours with mouse
a -SM actin primary antibody (1:400, Sigma) and then
with goat anti-a –SM actin secondary antibody (1:400,
Vector Laboratories, Inc) for 30 minutes. The staining
for a -SM actin was completed with a VIP substrate kit
(Vector Laboratories, Inc). Light green stain (1
minute) was used for counterstaining.
Statistical methods. All statistical analyses were
performed with the GraphPAD InStat software
(GraphPAD Software, Version 1.12a, Shreveport, La).
The mean and the standard deviation of the mean
(SD) for the H(e) levels and the percent stenosis was
calculated for both the H(e) group and the control
group. The H(e) levels and the percent stenosis for the
H(e) group was compared with the control group
with the Mann-Whitney test. The serum H(e) levels
were compared with the percent stenosis with a linear
regression model.
With the additional 3 animals for each group, the
total number of cells that were stained for BrdU, for
a -SM actin, and for both BrdU and a -SM actin in
the area of IH were determined. The mean percent-
age of the cells stained were determined for each
group: BrdU compared with the total number of
cells, a -SM actin compared with the total number of
cells, and BrdU and a -SM actin positive cells. The
BrdU and a -SM actin data for the control versus the
H(e) groups were compared with the Mann-
Whitney test.
All of the animal care, the routine handling, the
practices, and the procedures for this study, including
the animal health monitoring, the diets, the cages,
the environmental control, and the means of identi-
fication, met the standards described in the Animal
Welfare Regulations and the “Guide for the Care and
Use of Laboratory Animals” (National Institutes of
Health, publication 86-23, revised 1985). The pro-
tocol for the animal studies was approved by the
Veterans Administration Animal Care and Use
Committee (No. 7-96-2).
RESULTS
All of the animals survived the procedure except
1 rat in the H(e) group that died at the time of anes-
thetic administration before the operation. All of the
carotid arteries that underwent endarterectomy
were patent by gross inspection at the time of the
harvest, and no arteries had evidence of thrombosis.
The vessel measurements and the calculations for
each individual study rat from the control and H(e)
groups are listed in Table II. The mean and the SD
for the circumference of the outer limit of IH was
1.86 mm ± 0.21 for the control group and 2.13 mm
± 0.14 for the H(e) group (P = .008). The mean and
the SD for the area of the outer limit of IH in the
control group was 0.28 mm2 ± 0.06 and in the H(e)
group was 0.36 mm2 ± 0.05 (P = .008).
The mean and the SD for the H(e) levels in the
H(e) group and the control group were calculated
(Fig 1). The mean serum H(e) level in the H(e)
group was 36.32 m mol/L ± 15.28. This was more
than 6 times greater than the level for the control
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Fig 1. Serum homocysteine levels for homocysteine
group (n = 8) and control group (n = 9; *P = .0007).
Fig 2. Amounts of intimal hyperplasia, expressed as per-
cent stenosis, for homocysteine group (n = 8) and control
group (n = 9; *P = .0007).
group, which was 5.53 m mol/L ± 2.06, with a P
value of .0007.
The mean and the SD for the amount of IH,
expressed as percent lumen stenosis, was determined
for the H(e) and the control groups (Fig 2). The
percent lumen stenosis was 21.89% ± 4.82% in the
H(e) group and 4.82% ± 1.64% in the control group
(P = .0007). This comparison showed more than a
4-fold increase in IH in the H(e) group when calcu-
lated as lumen stenosis. The data from the actual IH
measurements (Table II) show an 8-fold increase in
the IH area. However, the percent lumen stenosis is
more accurate because it is a normalized value. This
analysis of IH shows that approximately 78% of the
lumen remains in the group with elevated H(e) lev-
els versus 95% in the control group. Fig 3 is a repre-
sentative photomicrograph of the elastin-stained sec-
tions that reveals minimal IH in the control group
(A1, A2) as compared with a greater amount of IH
formation in the H(e) group (B1, B2). No evidence
of thrombosis was seen in these specimens or in any
of the specimens in both the control and the H(e)
groups. Note that the internal elastic lamina is
absent. A partial removal of the external elastic lam-
ina is seen as a black staining line in B2, and the
organized medial smooth muscle cells are indicative
of the endarterectomy and the subsequent IH for-
mation. The increased amount of IH is clearly evi-
dent as disorganized cellular proliferation and extra-
cellular matrix deposition within the lumen of 
the H(e) group as compared with the decreased
amount of reaction seen in the control group. As
described below in the immunohistochemical data
description, the cells in the IH contain a -SM actin
and are primarily of smooth muscle or myofibrob-
last origin.14,15 The nylon suture line is evident in
the sections.
A linear regression model was used to compare
the relationship between the serum H(e) levels and
the percent stenosis. An analysis of the serum H(e)
levels versus the percent stenosis showed a linear
relationship with an r2 value of 0.72 (Fig 4). As the
serum H(e) levels increase, a corresponding increase
is seen in the amount of IH and, thus, the lumen
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Table I. Homocysteine and control group diet components
Ingredients Control group (g/kg) Homocysteine group (g/kg)
L-arginine 12.7 12.7
L-histidine 3.4 3.4
L-lysine-HCl 9.1 9.1
L-tyrosine 5.7 5.7
L-tryptophan 1.8 1.8
L-phenylalanine 7.3 7.3
L-methionine 1.7 0.0
L-cystine 3.7 3.7
L-threonine 4.6 4.6
L-leucine 10.5 10.5
L-isoleucine 6.1 6.1
L-valine 6.3 6.3
Glycine 6.2 6.2
L-proline 7.6 7.6
L-glutamic acid 28.9 28.9
L-alanine 5.1 5.1
L-aspartic acid 15.8 15.8
L-serine 7.2 7.2
Total L-amino acid 143.7 142.0
Cornstarch 100.0 100.0
Dextrin 100.0 100.0
Cellulose 50.0 50.0
Sucrose 392.19 403.87
Sodium bicarbonate 4.3 4.3
Corn oil 50.0 50.0
Primex 100.0 100.0
Salt mix (no Fe added) 35.0 35.0
Vitamin mix 10.0 (with folate*) 10.0 (without folate)
Choline bitartrate 14.48 0.0
Ferric citrate, USP 0.33 0.33
DL-homocysteine 0.0 4.5
*Folate, 2.0 mg/10 mg vitamin mix; USP, United States Pharmacopeia.
Differences between diets are highlighted in bold print.
stenosis that is closely associated with the degree of
H(e) elevation.
An examination of the double immunohisto-
chemical staining in the additional 3 rats per group
for BrdU and a -SM actin in the area of IH revealed
the mean percentage of total cells stained for a -SM
actin in the control group to be 99.0% ± 0.5% and in
the H(e) group to be 95.0% ± 2.4%. The mean per-
centage of total cells in the IH area stained for BrdU
was 10.1% ± 2.6% in the control group and 23.0% ±
7.1% in the H(e) group (P = .04). Finally, the mean
percentage of cells stained for BrdU and a -SM actin
was 9.3% ± 2.6% in the control group and 19.1% ±
5.6% in the H(e) group (P = .05).
DISCUSSION
Many studies have examined hyperhomocys-
teinemia and its association with various cardiovas-
cular disease processes, such as peripheral, coronary,
and carotid artery disease, and outcomes, such as
stroke, myocardial infarction, and claudication.16
However, to our knowledge, this is the first study to
examine the increased IH development after CEA in
an environment of hyperhomocysteinemia in rats.
Studies that examined elevated serum H(e) have
found an association with carotid artery thickening
in patients who were asymptomatic17 and sympto-
matic atherosclerotic disease involving the coronary,
peripheral, and cerebral circulation,16 but none have
examined the development of IH after surgery. This
preliminary study, although small, limited in scope,
and focused on 1 H(e) dose and 1 post-CEA time
point, is significant in that it may provide some
insight into a causal factor for IH and it may provide
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Fig 3. Photomicrograph of elastin-stained rat common carotid artery sections 2 weeks after
CEA. Sections A1 and A2, from an animal in the control group, show significantly less neointi-
mal hyperplasia than sections B1 and B2, from animals in the homocysteine group with elevat-
ed homocysteine levels. Magnification was · 10 (A1 and B1) and · 40 (A2 and B2). A2 and B2
are magnified sections of vessels seen in A1 and B1. Darker blue staining near the lumen is iden-
tified as area of IH. Note lack of internal elastic lamina in A2 and B2 and partial removal of exter-
nal elastic lamina in B2. Remaining external elastic lamina is seen as thin black staining line.
Fig 4. Linear regression model of serum homocysteine
levels and percent stenosis (y = 4.38 + 0.42x; df = 15; r2 =
0.72; P = .0001).
for a means of decreasing IH in various different sce-
narios that are encountered in vascular surgery.
Most rat carotid injury models involve a 2F 
balloon tip catheter introduced retrograde via the
external carotid artery into the common carotid
artery in an environment of normal serum
H(e).5,12,18,19 The catheter is passed through the
carotid artery several times, which denudes the
endothelial cell monolayer and stretches the vessel
wall. Vessel injury occurs but is unlike that which
occurs with human CEA operative conditions. A rat
CEA with an arteriotomy, an intima and medial
removal, and a suture closure has been shown to be
feasible.20 We modified this technique by obtaining
vessel control with occlusion tourniquets and by
using a continuous suture line. The following advan-
tages are seen in this model: it more closely resem-
bles the operation performed in humans; there is
direct observable arterial wall manipulation and
injury; and a continuous suture line is used, and
there is no dilatation of the arterial wall. This model
has proved to be reproducible—given the significant
differences between the control and the H(e)
groups—and more applicable and thus, may be
applied to other areas of CEA investigation.
The interrelationship between vitamin status and
plasma H(e) was first reported by Kang et al,21 who
demonstrated an inverse relationship between H(e)
and plasma folate concentrations. The serum H(e)
level has been shown modestly to increase 6.22
m mol/L after 2 weeks of administering a folate-defi-
cient diet, without added H(e), to experimental ani-
mals versus control animals with a level of 4.85
m mol/L. Moreover, the homocysteinemia in rats with
low normal levels of serum folate was similar to that
observed in rats with subnormal folate levels, which
suggests that the efficient remethylation of H(e)
could not be attained in low normal levels of serum
folate.22 In light of these findings, this is the first
study to use a diet designed with a deficiency of
methionine and the methyl donors choline and folate
and with the addition of H(e). In this way, the H(e)
metabolic pathway is unable to proceed with the
breakdown of H(e), which accumulates. This ensured
a consistent significant supra physiologic elevation of
serum H(e) similar to levels found in patients with
homozygous metabolic enzyme defects. Once the ele-
vated H(e) levels were achieved with this diet modifi-
cation, its effects on IH were evaluated. The ability to
produce such elevations with a simple dietary modifi-
cation and without apparent confounding side effects
provides for a useful tool to study increased H(e) lev-
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Table II. Vessel wall measurements for the homocysteine and control groups after CEA
Circumference IH/OL-IH
Animal Area IH (mm2) OL-IH (mm) Area OL-IH (mm2) · 100 (% stenosis) H(e) level (m mol/L)
H1 0.08 1.97 0.31 25.8 37.10
H2 0.09 2.30 0.42 21.4 27.30
H3 0.11 2.24 0.40 27.5 24.45
H4 0.07 2.21 0.39 17.9 48.06
H5 0.08 2.19 0.38 21.0 28.14
H6 0.07 2.13 0.36 19.4 28.30
H7 0.10 2.13 0.36 27.8 69.10
H8 0.04 1.88 0.28 14.3 28.09
Mean 0.08 2.13 0.36 21.9 36.32
SD 0.02 0.14 0.05 4.8 15.28
C1 0.02 1.81 0.26 7.7 3.47
C2 0.01 2.07 0.34 2.9 3.33
C3 0.01 1.97 0.31 3.2 4.58
C4 0.01 1.66 0.22 4.5 4.06
C5 0.01 1.70 0.23 4.3 6.02
C6 0.02 2.24 0.40 5.0 10.03
C7 0.01 1.59 0.20 5.0 6.55
C8 0.02 1.88 0.28 7.1 5.99
C9 0.01 1.84 0.27 3.7 5.75
Mean 0.01 1.86 0.28 4.8 5.53
SD 0.005 0.21 0.06 1.6 2.06
P value .0007 .008 .008 .0007 .0007
IH, Neointimal hyperplasia; OL-IH, outer limit of neointimal hyperplasia; H(e), homocsyteine; H1-H8, homocysteine group; C1-C9,
control group; SD, standard deviation of the mean.
P values compare mean values for H(e) group versus control group.
els in different disease processes and treatment of the
increased H(e) levels.
Another application for this model would be the
continued study of the mechanisms by which H(e)
contributes to vascular disease. The literature is
replete with proposed mechanisms of action whereby
H(e) promotes vascular injury and disease. McCully23
demonstrated the direct toxic effect of H(e) on cul-
tured endothelial cells, possibly as a result of the
known cellular toxin H(e) thiolactone,  by extracellu-
lar matrix modification of proteoglycans.23
Hyperhomocysteinemia may also affect normal
wound healing and vascular repair. Vascular repair
and associated neointimal formation have been asso-
ciated traditionally with smooth muscle cell prolifer-
ation and migration from the media. In vivo studies
have shown that oral administration of H(e) leads to
significantly increased aortic cyclin–dependent kinase
protein levels and to increased cellular proliferation as
evaluated by BrdU incorporation. These increases
paralleled H(e) levels and confirmed the role of
hyperhomocysteinemia in the induction of vessel wall
growth, proliferation, and thickening.24,25 This
effect of increased serum H(e) on vascular smooth
muscle may play a role in explaining the mechanisms
of action for the development of IH after CEA.
Recently, Shi et al14 have shown that vascular
injury repair and remodeling involves fibroblast acti-
vation, proliferation, migration, and differentiation
to myofibroblasts as shown by the expression of a -
SM actin. Remodeling has also been proposed as
part of the explanation for lumenal decreases after
balloon vessel injury.14 An evaluation of the mor-
phometric data (Table II) reveals that the circumfer-
ence and the area of the outer limits of IH are sig-
nificantly greater in the H(e) group versus the con-
trol group. A small circumference or area of the
outer limit of IH would be the expected finding if
remodeling was the explanation for the lumen
stenosis. If this had been the case, the calculated per-
cent stenosis of the vessels would have been even
greater. Because the investigator was blinded, the
measurement bias did not play a role in this finding.
These results do not support the theory that con-
tractile forces, associated with myofibroblasts, are
attributing to the decrease in lumen area. However,
remodeling may be present and may affect cellular
migration and proliferation.
The double immunohistochemical staining data
confirm that the primary cell type within the IH is
a -SM actin positive and may either be smooth mus-
cle or myofibroblasts. An examination of the BrdU
data revealed that there were marginally significant
increases in the replication of cells found in the H(e)
group in an examination of the total population of
cells and in those that were stained for a -SM actin.
This suggests that there is an association between
hyperhomocysteinemia and increased IH smooth
muscle–myofibroblast migration and proliferation.
The close association between H(e) and coagula-
tion and between the coagulation cascade and IH is
well known and documented. One possible mecha-
nism of action of increased IH in hyperhomocys-
teinemic rats is its role on coagulation factors.
Although no detailed analysis of coagulation factors
was undertaken in this model, we observed no
thrombus formation grossly or at the time of sec-
tioning in any carotid sample. Perhaps before the 2-
week time point, some coagulation defect did occur
that resulted in increased IH. However, this is only
speculation at this time.
Normal serum H(e) levels have not been estab-
lished for rats, and, for that matter, normal human
serum H(e) levels are debatable. The upper limits of
normal human serum H(e) levels were determined
by Stampfer et al26 to be as high as 15.8 m mol/L,
and the risk for extracranial carotid artery stenosis
was increased in subjects with H(e) concentrations
as low as 11.4 m mol/L.9 In our study, the control-
group animals were administered diets with standard
multivitamin preparations, including folate, B6, and
B12. It is concluded that the mean H(e) level for the
control group can be used as the “normal” serum
H(e) level and can be used for comparison.
The consistent supra physiologic elevation of
serum H(e) levels was associated with more than 4
times the amount of IH after a CEA as compared with
those with normal H(e) levels (Fig 2). We anticipate
that a longer postoperative period could possibly
result in a more dramatic lumen diameter reduction,
such that this lesion would be hemodynamically sig-
nificant. Although other CEA models (balloon
injury) appear to show a maximal lumen reduction
effect at 2 weeks, we believe that, in the environment
of continually elevated H(e), the IH will continue to
encroach on the lumen. Also, there was a clear linear
relationship between the serum H(e) level and the
development of postoperative IH and restenosis at
this time interval (Fig 4). We believe that this is a
causal relationship because of the highly statistically
significant results with a comparatively small sample
size. In addition, the correlation analysis is highly
indicative that an ever-increasing serum H(e) milieu
results in a step-wise increase in lumen diameter
reduction as a result of IH. The H(e) levels obtained
in this study are nearly double those normally consid-
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ered elevated and those in the range of patients with
homozygous defects in cystathionine b -synthase.
Studies with this rat CEA model and with a decreased
amount of H(e) added to the diet are needed to attain
elevated levels in line with those that are seen clinical-
ly. It is known that a deficiency of folate and other vit-
amins is associated with the accumulation of H(e) and
that hyperhomocysteinemia is found not only in sub-
jects with subnormal serum folate but also in those
with low normal serum folate levels.22 What is not
known is at what level of folate does the lowest con-
centration of H(e) occur and how will this affect the
formation of IH.
Clowes et al5 in a balloon carotid artery injury
model with no changes in H(e) levels have shown
that total smooth muscle cells reach a maximum
number at 2 weeks and then subsequently do not
significantly change despite the continued prolifera-
tion of the luminal smooth muscle cells. Therefore,
in this preliminary study, a period of 2 weeks was
chosen to be the initial postoperative investigation of
the effects of H(e) in a post-CEA model. Future
investigations will include the lengthening of the
postoperative period to more closely examine the
long-term effect of hyperhomocysteinemia outside
the perioperative period and to examine the nonop-
erative contralateral carotid artery controls from the
study rats to investigate vessel wall changes in a non-
operative state. Dietary modulation is needed to
establish the maximum benefit of dietary manipula-
tion of H(e) levels and its effect on postoperative IH
by repleting the folate in varying combinations.
The implication from this preliminary study is
that, the lower the serum H(e) level, the less the
progression of carotid artery IH after CEA. Our
regression analysis data clearly showed this associa-
tion between lower H(e) levels and minimal IH. The
lowest limit of serum H(e) and associated decreased
IH is yet to be established. This important factor,
the decrease of H(e) from supra physiologic to phys-
iologic levels and the reassessment of its role in IH,
is the focus of further work. This study suggests that
rats with increased H(e) levels are more prone to IH
and subsequent restenosis after CEA.
An application to clinical scenarios of these pre-
liminary animal model results of increased H(e) lev-
els associated with increased IH after CEA would be
premature. However, the results of this work could
lead to a scenario where patients are screened before
surgery for detection of hyperhomocysteinemia and
possible correction with vitamin supplementation to
decrease the incidence rate of recurrent stenosis. In
humans, it is known that up to 40% of patients for
strokes have elevated H(e) levels,10,27 as compared
with approximately 6% of the general population.
What is not known is the percent of patients who
undergo CEA, and who subsequently have resteno-
sis, who have elevated or relatively high normal lev-
els of serum H(e) and would potentially benefit
from prophylactic treatment to normalize the H(e)
level. Further clinical investigation will be required
to establish the efficacy of such treatment.
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